Skip to content

    Pulmonx (LUNG) stock price & financials

    View LUNG earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+28.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $20.39M
    $23.77M
    $22.54M
    $23.86M
    $21.50M
    +5.5%
    $22.60M
    -4.9%
    $20.59M
    -8.7%
    $22.76M
    -4.6%
    Weakening
    Operating Profit
    -$14.13M
    -$13.42M
    -$14.56M
    -$14.80M
    -$14.39M
    -1.9%
    -$9.90M
    +26.2%
    -$12.96M
    +11.0%
    -$9.06M
    +38.8%
    Strengthening
    Net Profit
    -$14.14M
    -$13.18M
    -$14.45M
    -$15.17M
    -$13.96M
    +1.3%
    -$10.43M
    +20.9%
    -$13.65M
    +5.5%
    -$10.08M
    +33.6%
    Strengthening
    EPS
    $-0.36
    $-0.36
    $-0.38
    $-0.34
    +5.6%
    $-0.33
    +8.3%
    $-0.24
    +36.8%
    Strengthening
    Other Income
    Interest
    $891.0K
    $842.0K
    $781.0K
    $799.0K
    $805.0K
    -9.7%
    $770.0K
    -8.6%
    $976.0K
    +25.0%
    $1.22M
    +52.4%
    Strengthening
    Depreciation
    Profit before Tax
    -$13.95M
    -$13.14M
    -$14.31M
    -$15.00M
    -$13.83M
    +0.9%
    -$10.24M
    +22.1%
    -$13.51M
    +5.6%
    -$9.95M
    +33.7%
    Strengthening
    MarginsOPM
    -69.3%
    -56.5%
    -64.6%
    -62.0%
    -66.9%
    +3.4%
    -43.8%
    +22.4%
    -62.9%
    +2.6%
    -39.8%
    +35.9%
    Strengthening
    Tax
    -1.4%
    -0.3%
    -0.9%
    -1.2%
    -0.9%
    +32.6%
    -1.8%
    -527.6%
    -1.1%
    -17.0%
    -1.3%
    -13.6%
    Weakening
    ReturnsROIC
    2.6%
    2.4%
    2.6%
    2.8%
    2.6%
    -1.3%
    1.9%
    -20.9%
    2.5%
    -5.5%
    1.8%
    -33.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$4.12M$14.77M$231.56M$148.48M$101.74M$83.55M$70.91M$69.75M$55.84M
    Short-Term Investments
    Total Current Assets$41.07M$249.99M$208.00M$168.95M$150.42M$136.25M$101.68M$88.13M
    Net PP&E$7.46M$10.45M$12.89M$10.50M$7.43M$21.45M$20.25M$19.15M
    Goodwill$2.33M$2.33M$2.33M$2.33M$2.33M$2.33M$2.33M$2.33M
    Intangibles$524.0K$400.0K$277.0K$154.0K$31.0K$0
    Total Assets$53.53M$263.71M$235.17M$193.68M$177.78M$162.85M$129.29M$114.73M
    LiabilitiesTotal Current Liabilities$14.16M$12.53M$17.55M$18.49M$23.16M$24.44M$20.06M$20.41M
    Short-Term Debt$0$91.0K$90.0K$2.15M$3.18M$106.0K$103.0K
    Long-Term Debt$17.37M$17.32M$17.23M$35.09M$34.00M$36.99M$37.43M
    Long-Term Leases$6.40M$7.62M$6.84M$3.85M$1.11M$18.52M$18.06M$17.40M
    Total Liabilities$35.57M$37.57M$41.93M$39.67M$59.47M$77.04M$75.17M$75.54M
    EquityCommon Stock & APIC$2.0K$36.0K$37.0K$38.0K$39.0K$40.0K$42.0K$43.0K
    Retained Earnings-$210.50M-$242.73M-$291.39M-$350.32M-$411.16M-$467.56M-$521.56M-$545.29M
    Total Equity-$167.33M-$187.38M$226.13M$193.24M$154.01M$118.31M$85.81M$54.12M$39.20M
    HighlightsNet Cash / (Debt)$214.19M$131.06M$84.41M$46.30M$33.73M$32.66M$18.31M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$18.39M-$20.77M-$30.63M-$41.39M-$45.08M-$37.61M-$31.54M-$32.38M-$30.56M
    Cash from Investing$200.0K-$14.23M$12.69M-$46.26M-$4.22M-$2.01M$17.48M$30.48M$8.69M
    Cash from Financing$12.11M$45.62M$234.83M$4.46M$2.42M$21.40M$1.36M$833.0K$1.75M
    SummaryCapital Expenditure-$316.0K-$720.0K-$911.0K-$3.67M-$1.32M-$807.0K-$1.45M-$452.0K-$112.0K
    Free Cash Flow-$18.71M-$21.48M-$31.54M-$45.06M-$46.40M-$38.42M-$32.98M-$32.83M-$30.67M
    FCF Margin-93.5%-65.9%-96.4%-93.1%-86.5%-55.9%-39.4%-36.3%-35.1%

    Ratios